Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden
SureSeq myPanel™ NGS Custom Cancer Panels enable researchers to create bespoke probe panels from an expert-curated library
New SureSeq™ FFPE DNA Repair Mix delivers excellent sequencing data for confident variant calling from minimal DNA input
New whitepaper demonstrates how customizable, medically focused array designs complement NGS for clinical genetics research
New NGS products for streamlined sample prep and ovarian cancer research
